BMJ--Lessons from the withdrawal of rofecoxib

Posted by Clark Venable on 10/14/2004

British Medical Journal: Lessons from the withdrawal of rofecoxib:

""Suggested measures to ensure drug safety before definite licensing of a drug:
  • Legal requirement for drug companies to register all randomised controlled trials prospectively
  • Legal requirement for drug companies to make all data on serious adverse events from clinical studies publicly available immediately after study completion
  • Continuously updated systematic reviews of adverse events based on published and unpublished data from randomised controlled trials and observational studies
  • Phased introduction of new interventions in independent, large scale, randomised trials before definite drug licensing
  • Clear cut financial firewalls between pharmaceutical companies and researchers performing systematic reviews and clinical studies

This post has 0 replies
See full thread

Feeds and Categories

Blog Roll

Google Modules
   Body Mass Index
   Allowable Blood Loss

   The Ether Way
   Westmead Anaesthesia Blog
   Book of Joe
   i'm so sleepy

   Aggravated DocSurg
   Retired Doc
   Finger and Tubes
   Running A Hospital
   Chance To Cut
   DB's Medical Rants
   Palmdoc Chronicles
   The Well-Timed Period


Geeks Like Me
   Seth Dillingham
   Jonathan Greene